Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Carcinoembryonic Antigen. Found 6 abstracts

Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Denlinger CS, Cohen SJ. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies. Current treatment options in oncology. 2007 Oct;8(5):339-51.
Householder J, Han A, Edelson MI, Eager JM, Rosenblum NG. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Archives of pathology & laboratory medicine. 2002 Sep;126(9):1101-3.
Adams GP, Weiner LM. Radioimmunotherapy of solid tumors: from fairytale to reality. Cancer Biother Radiopharm. 2001 Feb;16(1):9-11.
von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin Cancer Res. 2000 Jun;6(6):2219-28.
Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochimica et biophysica acta. 1999 Mar 25;1423(2):C11-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Carcinoembryonic Antigen

Carcinoembryonic Antigen blood Human therapeutic use analysis Biological Tumor Markers genetics Neoplasms Non-US Gov't Support Adenocarcinoma Female Male Adult metabolism therapy pathology immunology CA-125 Antigen Antineoplastic Combined Chemotherapy Protocols Radiopharmaceuticals Immunohistochemistry Guanylate Cyclase Mononuclear Leukocytes p53 Genes Tumor Biomarkers Endonucleases Immunoglobulin Fragments Pilot Projects Loss of Heterozygosity Antibody Affinity DNA-Binding Proteins Antigen-Antibody Reactions Radioimmunodetection tumor marker Enzyme-Linked Immunosorbent Assay Drug Dose-Response Relationship Vimentin Iodine Radioisotopes Synthetic Vaccines Neoplasm Antigens Peptide Receptors biosynthesis Treatment Outcome Radioimmunotherapy Neoplasm Proteins Biopsy Ca 19-9 Pulmonary Surfactants Neoplasm Antibodies Regression Analysis Middle Age alpha-Fetoproteins Gene Expression Profiling Gastrointestinal Neoplasms CA-19-9 Antigen Middle Aged Rectal Neoplasms Epidermal Growth Factor Receptor Microsatellite Repeats US Gov't Support-PHS metastatic colorectal adenocarcinoma Animal Sensitivity and Specificity Organoplatinum Compounds Monoclonal Antibodies Immunoglobulin G Thymidine Phosphorylase Cea Radiosurgery Chimeric Proteins Drug Design CD80 Antigens Papillary Adenocarcinoma Prognosis Colorectal Neoplasms Interferon Type II Fluorouracil Predictive Value of Tests T-Lymphocytes Ovarian Neoplasms Lactate Dehydrogenases Thymidylate Synthase Cadherins radiotherapy Case Report Lung Neoplasms ras Genes diagnosis Mutation chemistry pharmacokinetics Avipoxvirus surgery toxicity diagnostic use Neoplasm Circulating Cells radionuclide imaging secondary Leucovorin Prostate-Specific Antigen Aged Chorionic Gonadotropin Fluorine Radioisotopes drug therapy Microsatellite Instability Molecular Weight Mice
Last updated on Wednesday, February 05, 2020